Rivaroxaban: A novel anticoagulant.
Indian J Med Sci
; 2010 Nov; 64(11) 520-528
Article
in En
| IMSEAR
| ID: sea-145574
ABSTRACT
For more than 50 years, warfarin has single-handedly ruled the world of anti-coagulation without any competition, whatsoever! The anticoagulant was made available in 1940 and since then no other anti-coagulant has ever been able to match it in the clinical arena. But it looks like that the advances in the field of anti-coagulation, for the first time, have seriously started to erode its base. This review takes a look at rivaroxaban, a direct factor Xa inhibitor and one of the most foremost competitors of warfarin.
Key words
Full text:
1
Index:
IMSEAR
Main subject:
Thiophenes
/
Blood Coagulation
/
Humans
/
Biological Availability
/
Cardiovascular Diseases
/
Factor Xa
/
Morpholines
/
Outcome Assessment, Health Care
/
Drug Monitoring
/
Pharmacovigilance
Language:
En
Journal:
Indian J Med Sci
Year:
2010
Type:
Article